Inari Medical, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Stryker Corporation finalizes its acquisition of Inari Medical, Inc., marking the completion of a merger agreement initiated in January 2025.
Stryker Corporation has announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share in cash, totaling approximately $4.9 billion, marking Stryker's entry into the high-growth peripheral vascular segment.
Inari Medical announced a 21% year-over-year revenue increase for the third quarter of 2024, along with an updated full-year revenue guidance.
Inari Medical's Chief Financial Officer, Mitch Hill, will retire on October 1, 2024, and will be succeeded by Kevin Strange, the current SVP of Finance, Accounting, Strategy and Business Development.
Inari Medical announced a 23% year-over-year revenue increase for the second quarter of 2024, driven by strong adoption of its medical devices and global expansion, and raised its full-year revenue guidance.
Inari Medical announced a 23.3% year-over-year revenue increase for the first quarter of 2024, driven by increased adoption of their procedures and new products, and raised its full-year revenue guidance.
Inari Medical held its annual stockholders meeting on April 24, 2024, where directors were elected, the company's auditor was ratified, and executive compensation was approved.
Inari Medical announced a 22.6% increase in revenue for the fourth quarter of 2023, driven by strong procedural growth and the acquisition of LimFlow.
Inari Medical, Inc. announces the resignation of director Kirk Nielsen effective after the 2024 annual meeting, leading to a reduction in the board size.
LimFlow S.A.'s financial statements for 2022 and the nine months ended September 30, 2023, reveal ongoing losses and a significant decrease in cash reserves prior to its acquisition by Inari Medical.